Is elevated factor VIII a risk factor for venous thromboembolism in Canada? [4]

Thrombosis and Haemostasis

Volumn 94, Issue 5, 2005, Pages 1112-1113

  Favaloro, Emmanuel J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8A;

BLEEDING TENDENCY; BLOOD GROUP ABO SYSTEM; CANADA; CORRELATION ANALYSIS; EVIDENCE BASED MEDICINE; GENOTYPE; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

EID: 27844612054     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-05-1112     Document Type: Letter

References (16)

1. Wells PS, Lanlois NJ, Webster MA et al. Elevated factor VIII is a risk factor for venous thromboembolism in Canada - is it necessary to define a new upper reference range for factor VIII. Thromb Haemost 2005; 93: 842-6.
2. Tripodi A. Levels of coagulation factors and venous thrombosis. Haematologica 2003; 88: 705-11.
3. Owen DJ, Maclean RM, Pellard S, Collins PW. High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated? Br J Haematol 2001; 113: 655-7.
4. Christina L, Benilde C, Michela C et al. High levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 2004; 124: 504-10.
5. Witsenburg CPJ, Rosendaal FR, Middeldorp JM et al. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation. Thromb Res 2005; 115: 387-92.
6. Bronte-Stewart B, Botha MC, Krut LH. ABO blood groups in relation to ischaemic heart disease. BMJ, 1962; 1: 1646-50.
7. Jick H, Slone D, Westerhohn B et al. Venous thromboembolic disease and ABO blood type. Lancet 1969; 1: 539-42.
8. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol, 1964; 10: 238-245.
9. Schleef M, Strobel E, Dick A et al. Relationship between ABO and secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Br J Haematol 2004: 128: 100-7.
10. Tirado I, Mateo J, Soria JM et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005; 93: 468-74.
11. Larsen TB, Johnsen SP, Gislum M et al. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 2005; 3: 300-4.
12. Souto JC, Almasy L, Muniz-Diaz E et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000; 20: 2024-8.
13. O'Donnell J, Laffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001; 11: 343-51.
14. O'Donnell J, Boulton FE, Manning RA et al. Genotype at the secretor blood group locus is a determinant of plasma von Willebrand factor level. Br J Haematol 2002; 116: 350-6.
15. De Visser MC, Sandkuijl LA, Lensen RP et al. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci. J Thromb Haemost 2003; 1: 1771-6.
16. Morange PE, Tregouet DA, Frere C et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol 2005; 128: 91-9.